908 Devices Q2: Another Solid Report

908 Devices delivered another revenue beat in Q2, as device sales continued to shine. Q2 revenues grew 23% year-over-year to $16.07 million, with product revenue up nearly 35.5% and the installed base expanding 23%. Management raised 2026 revenue guidance to $68–$70 million, implying 21–25% growth, while operating and net losses narrowed.

Earlier this week, we received second quarter results from 908 Devices ( MASS ). The mass spectrometry company has been one of the market's biggest winners since the start of 2025, with shares going from the